United States · Business magazines · Markets Insider (Business Insider)

Big Pharma's Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)

Published by Markets Insider (Business Insider) · United States 2 h ago

WSW, NY, October 21st, 2026, FinanceWireRecent acquisitions and licensing deals reveal what drugmakers want next: different biology, better dosing and treatments that can...

Read the full article on Markets Insider (Business Insider) Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (markets.businessinsider.com)

Also worth reading

Quartz

Microsoft and Alphabet object to blockchain versions of their shares—but their veto only goes so far

Fox Business

Boeing's largest 737 MAX jet wins FAA certification, clearing way for deliveries of 1,555 ordered planes

Forbes

Big Pharma's Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)

Share

Also worth reading

How to pay off debt: 10 strategies for 2026

Stolen SSN? A New Law Promises Faster Help From Social Security

Hackers Hijacked a System Retailers Trust. Now Staples Faces a $5 Million Loss

Microsoft and Alphabet object to blockchain versions of their shares—but their veto only goes so far

Boeing's largest 737 MAX jet wins FAA certification, clearing way for deliveries of 1,555 ordered planes

Nvidia Lines Up Six Suppliers To Expand AI Chip Capacity Through 2028